cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice Targeting CD38-dependent NAD+ metabolism to
Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect NNMT inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports Nicotinamide N methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions ScienceDirect Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



